Pancreatic Insufficiency Completed Phase 2 Trials for ALTU-135 (DB05330)

Also known as: Pancreatic failure / Pancreatic insufficiency (disorder) / Insufficiency pancreatic / Exocrine pancreatic insufficiency / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder)

IndicationStatusPhase
DBCOND0031191 (Pancreatic Insufficiency)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00095732Oral TheraCLECâ„¢ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic InsufficiencyTreatment